Fairly Good If Gilenya Royalty Issue Could Be Settled in 2 Years: Mitsubishi Chemical CFO

Mitsubishi Chemical Holdings CFO Hidefumi Date Mitsubishi Chemical Holdings, the parent company of Mitsubishi Tanabe Pharma, sees that it will be "fairly good" if arbitral proceedings over Novartis’ royalty payments tied to Gilenya (fingolimod) are settled in two years. “Such...read more